Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Molecular Pharmaceutics|May 26, 2011
Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasmsChiara Clementi, Keren Miller, Anna Mero, et al.Angewandte Chemie (International Ed. in English)|March 19, 2009
Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer-alendronate-taxane conjugateKeren Miller, Rotem Erez, Ehud Segal, et al.Bioorganic & Medicinal Chemistry|June 2, 2009
Enhanced cytotoxicity of a polymer-drug conjugate with triple payload of paclitaxelRotem Erez, Ehud Segal, Keren Miller, et al.HLA|July 5, 2019
Identification of the novel HLA-B allele, HLA-B*15:539, in a South-Sudanese individualGil Benedek, Mahmoud Abed El-Latif, Keren Miller, et al.Journal of Neuroimmunology|December 3, 2019
MIF -173G/C polymorphism is associated with NMO disease severityLivnat Brill, Adi Vaknin-Dembinsky, Omri Zveik, et al.Journal of Medicinal Chemistry|August 19, 2010
Toward development of targeted nonsteroidal antiandrogen-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-gadolinium complex for prostate cancer diagnosticsHanit Marom, Keren Miller, Yossi Bechor-Bar, et al.Biomaterials|March 8, 2011
Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxelAnat Eldar-Boock, Keren Miller, Joaquin Sanchis, et al.Molecular Pharmaceutics|May 7, 2011
Antiangiogenic antitumor activity of HPMA copolymer-paclitaxel-alendronate conjugate on breast cancer bone metastasis mouse modelKeren Miller, Anat Eldar-Boock, Dina Polyak, et al.Biomaterials|February 26, 2013
Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastasesKeren Miller, Chiara Clementi, Dina Polyak, et al.Journal of Neuroimmunology|April 7, 2016
Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in IsraelLivnat Brill, Micha Mandel, Dimitrios Karussis, et al.Pageof 2